Vascular pathologies and cognition in a population-based cohort of elderly people

The MRC Cognitive Function and Ageing Study (CFAS) is a prospective longitudinal study of a population-based cohort of elderly people in six UK sites, evaluated using psychometric instruments and questionnaires to elucidate physical and mental health. Data from the core study includes prevalence and incidence rates for dementia and longitudinal measures of cognitive decline together with data on genetic risk factors for dementia. A neuropathology study runs in collaboration with the core study based on premortem counselling of individual respondents or carers. Analysis of pathological data from the first 209 accumulated brain donations showed that both Alzheimer-type pathologies (ATP) and vascular pathologies (including congophilic amyloid angiopathy (CAA)) were common in both demented and non-demented respondents. Although many cases fulfil conventional diagnostic criteria for the pathological diagnosis of Alzheimer disease, the data differ from those published from conventional studies of hospital or memory clinic cohorts. In particular, there are individuals whose total burden of pathology is inappropriately high or low compared with their clinical dementia status, even when all pathologies are considered in a multivariable model of dementia risk factors (25% of respondents misdiagnosed from pathology findings). Vascular pathology is so common that few dementia cases lack a mixed component of both ATP and vascular lesions (pure AD cases, 21%). More recently, the study has examined white matter pathology in this cohort as a potential manifestation of small-vessel disease (SVD) in the ageing brain. Using an MRI strategy to image formalin-fixed brain slices, the study shows that white matter lesions (WMLs) are common (94% overall frequency) and are an independent risk factor for dementia using multivariable analysis.

[1]  I. McKeith,et al.  Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes , 1998, International journal of geriatric psychiatry.

[2]  J. O'Brien,et al.  Comparison of the pathology of cerebral white matter with post‐mortem magnetic resonance imaging (MRI) in the elderly brain , 2004, Neuropathology and applied neurobiology.

[3]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[4]  F. Schmitt,et al.  Alzheimer neuropathologic alterations in aged cognitively normal subjects. , 1999, Journal of neuropathology and experimental neurology.

[5]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[6]  Keith A. Johnson,et al.  Neuropathology of Cognitively Normal Elderly , 2003, Journal of neuropathology and experimental neurology.

[7]  C. Brayne,et al.  Apo E and Apo CI Loci Are Associated with Dementia in Younger But Not Older Late-Onset Cases , 1998, Dementia and Geriatric Cognitive Disorders.

[8]  F. Barkhof,et al.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.

[9]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[10]  K. Ishii,et al.  Changes in cerebral blood flow and oxygen metabolism related to magnetic resonance imaging white matter hyperintensities in Alzheimer's disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  T. Kurki,et al.  Relationship between vascular factors and white matter low attenuation of the brain , 1993, Acta neurologica Scandinavica.

[12]  T. Inoue,et al.  Formalin fixed brains are useful for magnetic resonance imaging (MRI) study , 1987, Journal of the Neurological Sciences.

[13]  J. Copeland,et al.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT , 1986, Psychological Medicine.

[14]  Scott T. Grafton,et al.  Comparison of postmortem magnetic resonance imaging and neuropathologic findings in the cerebral white matter. , 1991, Archives of neurology.

[15]  A Brun,et al.  White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments , 1990, Histopathology.

[16]  Lars-Olof Wahlund,et al.  Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains , 2002, Dementia and Geriatric Cognitive Disorders.

[17]  A. Hofman,et al.  Cerebral white matter lesions, vascular risk factors, and cognitive function in a population‐based study , 1994, Neurology.

[18]  D. Easton,et al.  Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population , 2002, Journal of medical genetics.

[19]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[21]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[22]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.